/

SEOVF

SERNOVA BIOTHERAPEUTICS INC.After hours

0.07800.00 0.00%USD

OTC Markets OTCPK · as of Oct 14, 15:54 ET · 15m delay

Open

0.0808

Prev close

0.0780

Day range

0.07800.0808

52-week range

0.06000.1400

Volume

63.89K0.74×

Mkt cap

29.46M

P/E ttm

7.80

Fwd P/E

—

EPS ttm

0.0100

Div yield

0.00%

Earnings

—

From 52w high

−44.29%

Price Chart

Yahoo Finance · delayed

SEOVFOct 14, 2026O 0.0808H 0.0808L 0.0780C 0.0780−0.0020 (−2.50%)Vol 63.89K

SMA 500.0786
SMA 2000.1016

1Y change −40.00% since Oct 13, 2025 close540 bars loadedTimes in America/New_YorkDraw from the left toolbar · click a drawing to edit · right-click for alerts and export

SEOVF SERNOVA BIOTHERAPEUTICS INC. · Last Guard Finance

DES

Key Statistics

Yahoo Finance

Performance

1 week: +11.43%
1 month: −2.50%
3 months: −13.33%
6 months: −40.00%
Year to date: −13.33%
1 year: −40.00%

Valuation & ownership

Market cap: 29.46M
Enterprise value: 44.00M
P/E (ttm): 7.80
Forward P/E: —
PEG ratio: —
Price / book: —
Price / sales (ttm): —
EV / EBITDA: -4.92
EPS (ttm): 0.0100
EPS (forward): —
Beta (5y monthly): 0.64
Dividend yield: 0.00%
Payout ratio: 0.00%
Shares outstanding: 377.64M
Float: 336.77M
Short % of float: —
Short ratio (days): —
Held by insiders: 10.51%
Held by institutions: 0.04%
Avg volume (3m): 86.81K
50-day average: 0.0788
200-day average: 0.1017
52-week change: −40.00%
S&P 500 52-week: +17.00%

Technicals (daily)

RSI (14): 50.4
vs 50-day SMA: −0.71%
vs 200-day SMA: −23.22%
50 / 200-day trend: ▼ 50 below 200
MACD vs signal: ▲ above
ATR (14) % of price: 8.43%
Realised vol (20d, ann.): 166.2%
From 52-week high: −44.29%
From 52-week low: +30.00%

ANR

Analyst Consensus

No analyst coverage for this instrument.

Financial Snapshot

Full statements →trailing twelve months

Revenue (ttm): —
Revenue growth (yoy): —
Earnings growth (yoy): —
Gross margin: 0.00%
Operating margin: 0.00%
Profit margin: 0.00%

DES

About SERNOVA BIOTHERAPEUTICS INC.

Yahoo Finance profile

Sernova Biotherapeutics Inc operates as a clinical-stage biotechnology company in Canada. The company develops regenerative medicine therapeutics comprising proprietary Cell Pouch, a bio-hybrid organ system to replicate natural body functions. Its Cell Pouch creates vascularized organs for the longevity and functionality of therapeutic cells and ensures containment for retrievability. Sernova Biotherapeutics Inc was formerly known as Sernova Corp. and changed its name to Sernova Biotherapeutics Inc in February 2025. Sernova Biotherapeutics Inc is based in Mississauga, Canada.

Sector: Healthcare
Industry: Biotechnology
Employees: 8
Headquarters: Mississauga, ON, Canada
Website: sernova.com
Officers: Mr. Jonathan M. N. Rigby M.B.A. President, CEO & Director
Mr. James T. Parsons CPA-CA, MAcc Chief Financial Officer
Ms. Marylyn Rigby Chief Communications Officer
Dr. Pericles Calias Ph.D. Chief Development Officer and Head of R&D

SEAS

Seasonality · SEOVF

2007–2026 · monthly returns

Strongest month Jan +10.85%Weakest month Oct −11.58%Averages use completed years only. Past seasonality doesn't predict future returns.

Year	Jan	Feb	Mar	Apr	May	Jun	Jul	Aug	Sep	Oct	Nov	Dec	Year
2026	33.3	-16.7	20.0	0.0	-8.3	-9.1	-20.0	12.5	-11.1	-2.5			−13.3%
2025	-6.7	0.0	-21.4	27.3	-7.1	-15.4	36.4	-13.3	0.0	-15.4	0.0	-18.2	−40.0%
2024	-9.4	-8.3	-6.8	-24.4	-12.9	-11.1	-16.7	0.0	-10.0	0.0	-5.6	-11.8	−71.7%
2023	45.8	-14.0	-10.8	3.0	-8.8	19.4	-6.8	-13.0	0.0	-5.0	-7.0	0.0	−10.2%
2022	-11.7	-8.6	-0.9	-1.7	1.8	-23.3	-5.6	-3.6	-25.9	-1.7	-3.4	3.5	−59.3%
2021	98.1	13.3	-0.8	-4.2	-7.1	10.5	-11.2	-2.9	-1.0	0.0	3.0	42.2	+173.6%
2020	0.0	-15.4	-18.2	11.1	50.0	46.7	-4.5	4.8	-4.5	-4.8	10.0	140.9	+307.7%
2019	-6.7	-7.1	0.0	23.1	6.3	11.8	-26.3	0.0	35.7	-21.1	0.0	-13.3	−13.3%
2018	-5.9	3.1	-18.2	0.0	-18.5	-22.7	0.0	0.0	0.0	-17.6	21.4	-11.8	−55.9%
2017	0.0	-5.0	5.3	-5.0	-5.3	-5.6	0.0	-5.9	6.3	17.6	0.0	70.0	+70.0%
2016	-13.6	-5.3	5.6	10.5	19.0	-16.0	19.0	-8.0	0.0	-8.7	-9.5	5.3	−9.1%
2015	7.7	7.1	0.0	6.7	-6.2	40.0	9.5	-21.7	33.3	-16.7	-10.0	22.2	+69.2%
2014	-7.1	100.0	0.0	-7.7	0.0	-4.2	-13.0	5.0	-14.3	-16.7	6.7	-18.8	−7.1%
2013	5.9	-16.7	13.3	-17.6	-14.3	-8.3	9.1	0.0	8.3	-7.7	0.0	16.7	−17.6%
2012	36.4	13.3	-11.8	53.3	-13.0	0.0	5.0	4.8	-18.2	5.6	-10.5	0.0	+54.5%
2011	0.0	5.9	11.1	5.0	0.0	-19.0	0.0	-23.5	0.0	-15.4	27.3	-21.4	−35.3%
2010	60.0	18.8	-15.8	-12.5	7.1	-13.3	0.0	-7.7	25.0	-13.3	30.8	0.0	+70.0%
2009	0.0	0.0	0.0	0.0	233.3	20.0	0.0	0.0	0.0	-16.7	0.0	0.0	+233.3%
2008	2.6	25.0	-50.0	40.0	-54.3	50.0	-29.2	5.9	0.0	-55.6	75.0	-78.6	−92.3%
2007			-25.2	4.7	-2.2	-13.6	-7.9	0.0	5.7	-27.0	-22.2	-7.1	−66.1%

INSD

Insider Activity · SEOVF

Market-wide insider buying →Congress trades →SEC Form 4 filings via Yahoo Finance

Buys, 6 months

0 shares

Sells, 6 months

— shares

Net shares

Net change in insider shares

—

Date	Insider	Transaction	Shares	Value
Jul 2, 2026	Sernova Biotherapeutics Inc.Issuer	—	115K	—
Apr 15, 2026	Sangha (Steven)Director of Issuer	Acquisition under a prospectus exemption at price 0.11 per share.	26.67M	$2.91M
Apr 13, 2026	Parsons (James T Cpa)Director of Issuer	Acquisition under a prospectus exemption at price 0.14 per share.	229.9K	$31.72K
Apr 13, 2026	Rigby (Jonathan M N)Director of Issuer	Acquisition under a prospectus exemption at price 0.14 per share.	229.9K	$31.72K

SEOVF

Price Chart

Keyboard shortcuts & functions

Anywhere

Command line

Charts (click the chart first)

Function codes

SEOVF

Price Chart

Key Statistics

Performance

Valuation & ownership

Technicals (daily)

Analyst Consensus

Financial Snapshot

About SERNOVA BIOTHERAPEUTICS INC.

Seasonality · SEOVF

Insider Activity · SEOVF

Congress Trades · SEOVF

Investors Holding SEOVF

Investors Holding SEOVF

Congress Trades · SEOVF

Insider Activity · SEOVF

Seasonality · SEOVF

Key Statistics

Performance

Valuation & ownership

Technicals (daily)

Analyst Consensus

Financial Snapshot

About SERNOVA BIOTHERAPEUTICS INC.

Earnings & Dividends

News